XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
Source:
Nasdaq GlobeNewswire
/
15 Mar 2024 14:34:50 America/Chicago
N/A
Share on,